Literature DB >> 8842633

Achieving a 96.6 percent follow-up rate in a longitudinal study of drug abusers.

L B Cottler1, W M Compton, A Ben-Abdallah, M Horne, D Claverie.   

Abstract

Longitudinal studies can be hampered by poor follow-up rates, seriously reducing generalizability of the findings. Understanding the barriers, as well as approaches to overcome and adapt to these impediments, resulted in a 96.6% 18 month follow-up rate of 479 drug abusers enrolled in an NIDA funded demonstration project aimed at reducing HIV transmission among St. Louis' most vulnerable drug-using population. In this paper, we discuss the importance of phone and systems tracking, creative team work and persistence and procedures for tracking out-of-treatment drug-users by analyzing the efforts needed to reach the study subjects. We also compared the characteristics of hard-to-reach respondents with those who were less difficult. The results revealed that employment status was the only characteristic associated with being hard-to-reach. Gender, race, age, education and psychiatric status did not discriminate recruitment difficulty in this sample. The study findings suggest that although unemployment predicted recruitment difficulty, and that the locator information provided by the respondent can be very helpful, a comprehensive tracking strategy as well as persistence and creative team work are the most important determinants of the rate of success of a follow-up investigation.

Entities:  

Mesh:

Year:  1996        PMID: 8842633     DOI: 10.1016/0376-8716(96)01254-9

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  60 in total

1.  Agency-based tracking of difficult-to-follow populations: runaway and homeless youth programs in St. Louis, Missouri.

Authors:  D E Pollio; S J Thompson; C S North
Journal:  Community Ment Health J       Date:  2000-06

2.  Compensation effects on clinical trial data collection in opioid-dependent young adults.

Authors:  Claire E Wilcox; Michael P Bogenschutz; Masato Nakazawa; George E Woody
Journal:  Am J Drug Alcohol Abuse       Date:  2011-09-22       Impact factor: 3.829

3.  How to design an effective treatment outcome study.

Authors:  Lisa M Najavits
Journal:  J Gambl Stud       Date:  2003

4.  A replicable model for achieving over 90% follow-up rates in longitudinal studies of substance abusers.

Authors:  Christy K Scott
Journal:  Drug Alcohol Depend       Date:  2004-04-09       Impact factor: 4.492

5.  OPERATIONAL LESSONS FROM THE PATHWAYS TO DESISTANCE PROJECT.

Authors:  Carol A Schubert; Edward P Mulvey; Laurence Steinberg; Elizabeth Cauffman; Sandra H Losoya; Thomas Hecker; Laurie Chassin; George P Knight
Journal:  Youth Violence Juv Justice       Date:  2004-01-01

6.  Predictors of Attrition in a Cohort Study of HIV Infection and Methamphetamine Dependence.

Authors:  J Cattie; M J Marquine; K A Bolden; L C Obermeit; E E Morgan; D R Franklin; A Umlauf; J M Beck; J H Atkinson; I Grant; S P Woods
Journal:  J Subst Use       Date:  2015-02-03

7.  Issues in designing and implementing a Spanish-language multi-site clinical trial.

Authors:  Lourdes Suarez-Morales; Julie Matthews; Steve Martino; Samuel A Ball; Carmen Rosa; Christine Farentinos; José Szapocznik; Kathleen M Carroll
Journal:  Am J Addict       Date:  2007 May-Jun

8.  Optimizing follow-up and study retention in the 21st century: Advances from the front line in alcohol and tobacco research.

Authors:  Lia J Smith; Patrick J McNamara; Andrea C King
Journal:  Drug Alcohol Depend       Date:  2017-04-15       Impact factor: 4.492

9.  Peer-delivered interventions reduce HIV risk behaviors among out-of-treatment drug abusers.

Authors:  L B Cottler; W M Compton; A Ben Abdallah; R Cunningham-Williams; F Abram; C Fichtenbaum; W Dotson
Journal:  Public Health Rep       Date:  1998-06       Impact factor: 2.792

10.  Study designs and evaluation models for emergency department public health research.

Authors:  Kerry B Broderick; Megan L Ranney; Federico E Vaca; Gail D'Onofrio; Richard E Rothman; Karin V Rhodes; Bruce Becker; Jason S Haukoos
Journal:  Acad Emerg Med       Date:  2009-11       Impact factor: 3.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.